PER

4.94%

8.5¢ percheron therapeutics limited

Chart, page-4255

First 4255 Last

Share
Profile

Follow
mephistophles

1,066 Posts.

498

21/10/21

09:46

Post #: 56958703
Share

Originally posted by mephistophles: ↑

Hey @George1972 @samfiodiving,

My opinion largely irrelevant (~500k shares and not as cluey as you lot), but I have to agree with a large deal being the desired outcome here. I'm not particularly fussed if there's a CR in the 30-40c region, although George makes an excellent point re risk mitigation that's given me some pause.

Anyway, that's not the point of this message...

I'm actually quite curious as to what you guys imagine happening with the potential PRV, if there is indeed a deal waiting?

In my limited (hence querying) experience, these are usually designated to be sold and the proceeds split evenly, but I've only seen this in deals where the big-fish is taking complete rights for drug A in region X. I don't imagine us doing a deal like that with ATL1102 UNLESS IT'S ABSOLUTELY MASSIVE, because mgmt know that we're potentially sitting on a platform drug?

i.e. A deal would more likely be centred around ATL1102, specifically for the treatment of DMD, in regions x and y?

Not sure if that might change anything with respect to the usual "split the proceeds from the sale of the PRV" line?

Cheers.

p.s. Tangentially, it could be quite interesting if [select-your-partner] runs the trial and we get access to the data for ROW. Apparently Asia (particularly Japan) is emerging as a profitable rare disease market. I assume we'd all like to see Aussie boys benefit from ATL1102 ASAP too

Expand

Apologies, I'm coming off the back of a >48h migraine so some of that read even worse than usual haha

Obviously the PRV is with the FDA, so I'm assuming the US is region x in the above - should have just said that US+EU rather than "regions x and y" etc etc

Good luck guys!

p.s. I started chuckling to myself while typing this as it struck me that migraines are probably an inflammatory disorder. Not sure if it's the weird euphoria that I get when they are passing, or if there's some genuinely amusing irony there

ANP Price at posting: 29.0¢ Sentiment: Buy Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Microcap Wrap: 5 explorers with news out today

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

RCE

Recce's R327 found effective against E.coli during clinical trial

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

There are more pages in this discussion • 1,651 more messages in this thread...

First 4255 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 8.5¢		Change 0.004(4.94%)		Mkt cap ! $76.63M

Open	High	Low	Value	Volume
8.1¢	8.5¢	8.1¢	$46.54K	563.7K

Buyers (Bids)

No.	Vol.	Price($)
2	164616	8.1¢

Sellers (Offers)

Price($)	Vol.	No.
8.5¢	100110	1

View Market Depth

No.	Vol.	Price($)
2	164616	0.081
5	215500	0.080
1	250000	0.079
3	71500	0.078
2	121300	0.077

Price($)	Vol.	No.
0.085	100110	1
0.087	125000	1
0.089	102263	2
0.090	146175	1
0.091	108000	1

Last trade - 15.55pm 28/06/2024 (20 minute delay)

PER (ASX) Chart

Chart, page-4255

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Ava Risk Group expands US presence with A$0.7M Substation Deal

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Microcap Wrap: 5 explorers with news out today

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Recce's R327 found effective against E.coli during clinical trial

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Chart, page-4255

Top Stories

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Ava Risk Group expands US presence with A$0.7M Substation Deal

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Microcap Wrap: 5 explorers with news out today

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Recce's R327 found effective against E.coli during clinical trial

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News